US$ 21.15
glp 1 review Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic and Meta-Analysis of 99,599 Patients GLP-1 Genetics: How Genes Affect
Description
(2024) 47:S15878

2023;382:1213 (FDA) USFaDA: FDA approves new drug treatment for chronic weight management, first since 2014

Soon after this, the company merged with Nordisk Insulin Laboratorium to form Novo Nordisk (Molteni)

doi: 10.1007/s13300-018-0458-5
